Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use

被引:52
作者
Sloop, RR
Cole, BA
Escutin, RO
机构
[1] Department of Neurology, Loma Linda Univ. School of Medicine, Loma Linda, CA
[2] Department of Neurology, Loma Linda University Medical Center, Loma Linda, CA 92354
关键词
D O I
10.1212/WNL.48.1.249
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Botulinum toxin type A (BTX-A) (Botox, Allergan, Irvine, CA) labeling recommends its use within 4 hours of reconstitution. Since BTX-A is available only in 100-unit vials, a substantial quantity is often discarded. Using eight volunteers, we measured the percent decline in extensor digitorum brevis (EDB) M-wave amplitude (percent paralysis) following injection of freshly reconstituted BTX (right EDB) and compared this with the decline following injection of BTX that was refrozen (-20 degrees C) or refrigerated (+4 degrees C) for 2 weeks (left EDB) after reconstitution. When analyzed as paired data, there was essentially no difference in the muscle paralysis resulting from fresh BTX compared with refrozen or refrigerated BTX, and no statistical difference between groups was noted. Reconstituted BTX-A that is subsequently refrigerated or refrozen for 2 weeks does not lose potency in humans.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 20 条
[1]   BLEPHAROSPASM AND ITS TREATMENT, WITH EMPHASIS ON THE USE OF BOTULINUM TOXIN [J].
BORODIC, GE ;
COZZOLINO, D .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1989, 83 (03) :546-554
[2]  
BRIN MF, 1993, J ROY SOC MED, V86, P494
[3]  
CLARKE CE, 1992, Q J MED, V82, P197
[4]   EFFECTS OF BOTULINUM TOXIN ON NEUROMUSCULAR-TRANSMISSION IN RAT [J].
CULLCANDY, SG ;
LUNDH, H ;
THESLEFF, S .
JOURNAL OF PHYSIOLOGY-LONDON, 1976, 260 (01) :177-203
[5]   TREATMENT OF BLEPHAROSPASM WITH BOTULINUM TOXIN - A PRELIMINARY-REPORT [J].
FRUEH, BR ;
FELT, DP ;
WOJNO, TH ;
MUSCH, DC .
ARCHIVES OF OPHTHALMOLOGY, 1984, 102 (10) :1464-1468
[6]   Cosmetic denervation of the muscles of facial expression with botulinum toxin - A dose-response study [J].
Garcia, A ;
Fulton, JE .
DERMATOLOGIC SURGERY, 1996, 22 (01) :39-43
[7]   CRYSTALLINE PREPARATION OF BOTULINUM TOXIN TYPE-A (BOTOX) - DEGRADATION IN POTENCY WITH STORAGE [J].
GARTLAN, MG ;
HOFFMAN, HT .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1993, 108 (02) :135-140
[9]  
GREENE P, 1990, NAT I HLTH CONS DEV, P53
[10]   USE OF BOTULINUM TOXIN TYPE-F INJECTIONS TO TREAT TORTICOLLIS IN PATIENTS WITH IMMUNITY TO BOTULINUM TOXIN TYPE-A [J].
GREENE, PE ;
FAHN, S .
MOVEMENT DISORDERS, 1993, 8 (04) :479-483